Results 31 to 40 of about 6,366 (207)

Attention Deficit Disorder and Epilepsy

open access: yesPediatric Neurology Briefs, 2005
The relation between ADHD and epilepsy is evaluated in a review from New York Methodist Hospital, Brooklyn, New York.
J Gordon Millichap
doaj   +1 more source

Patterns of Medication Prescription among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United States

open access: yesChildren, 2022
The objectives of this study are to: (1) quantify the difference in the annual number of prescription medications (total and unique) between children and adolescents with ADHD and those without ADHD; and (2) identify the most prescribed medication ...
Abdulkarim M. Meraya
doaj   +1 more source

Characteristics of drug and dietary supplement inquiries by college athletes. [PDF]

open access: yes, 2010
BackgroundIn the United States, the National Center for Drug Free Sport manages the drug-testing programs for athletes of the National Collegiate Athletic Association (NCAA).
Ambrose, Peter J   +3 more
core   +1 more source

Practice Variables in Treatment of ADHD

open access: yesPediatric Neurology Briefs, 1999
The clinical characteristics and treatment methods used for children with ADHD were examined by questionnaires sent to 81 practicing psychiatrists and analyzed at the American Psychiatric Association, Washington, DC.
J Gordon Millichap
doaj   +1 more source

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor

open access: yesFrontiers in Psychiatry, 2022
Opioids and stimulants are often used in combination for both recreational and non-recreational purposes. High-efficacy mu opioid agonists generally increase the behavioral effects of stimulants, whereas opioid receptor antagonists generally attenuate ...
Mark A. Smith   +16 more
doaj   +1 more source

Cognitive Enhancement: Treating or Cheating? [PDF]

open access: yes, 2015
In this article I provide an overview of the moral and medical questions surrounding the use of cognitive enhancers. This discussion will be framed in light of 4 key considerations: (1) is there a difference between therapy and enhancement?
Whetstine, Leslie M.
core   +1 more source

Single-Dose Amphetamines in ADHD

open access: yesPediatric Neurology Briefs, 2001
The efficacy and time course of single morning doses of Adderall®, extended-release (Spansules), and immediate-release (tablets) dextroamphetamine sulfate (DXA) and placebo were compared in 35 children with attention-deficit/hyperactivity disorder (ADHD)
J Gordon Millichap
doaj   +1 more source

Stimulant induced Dermatological and Vascular Complications in patients with ADHD: A literature review

open access: yesEuropean Psychiatry, 2022
Introduction Methylphenidate and amphetamine are the two most widely used stimulants in managing Attention Deficit Hyperactivity Disorder (ADHD)1. Reynaud’s phenomenon (RP) is a reversible distal vasoconstriction presenting with various dermatological ...
F. Arain   +5 more
doaj   +1 more source

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT) [PDF]

open access: yes, 2013
Background and aims: Many patients presenting multiple behaviors including drug and food abuse as well as other pathological repetitive unwanted activities such as gambling, self-mutilation and paraphilias may not be appropriately diagnosed.
Barh, Debmayla   +13 more
core   +1 more source

Treatment effects of stimulant medication in young boys with fragile X syndrome [PDF]

open access: yes, 2011
Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and is caused by a CGG repeat expansion at Xq27.3 on the FMR1 gene.
Jane E. Roberts   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy